$PFE Headlines Pfizer a buy after merger talks break

New Post Public Reply Private Reply Replies (0) Message Board

Jun 2, 2014 at 3:02 PM

$PFE Headlines

Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin

Mylan settles Celebrex patent suit 1:30 p.m. Today - Seeking Alpha
3 Stocks Advancing The Drugs Industry 1:03 p.m. Today - TheStreet.com
7 Stocks That Will Lift the Dow Jones Industrial Average to New High 12:33 p.m. Today - TheStreet.com
3 Stocks Reiterated As A Buy: PFE, UNH, OXY 9:59 a.m. Today - TheStreet.com
Today's Market: Shareholders To Push For Change At These Companies? 9:25 a.m. Today - Seeking Alpha
Mylan, Pfizer Settle on Generic Celebrex 7:44 a.m. Today - The Wall Street Journal Interactive Edition
Drug Firms Target Smaller Deals 7:21 a.m. Today - The Wall Street Journal Interactive Edition
Retirement Strategy: ETF Portfolio Vs. The Stock Only Portfolio: Surprise, Surprise! 7:30 a.m. May 31, 2014 - Seeking Alpha
When Fraud Bites Business: Lost Fortunes, Reputations and Lives 10:30 p.m. May 30, 2014 - InvestorPlace.com
Dividend Stocks Vs. Junk Bond Yields 3:32 p.m. May 30, 2014 - Seeking Alpha
Court Backs Exclusive Period for Teva's Generic Celebrex Sales 1:33 p.m. May 30, 2014 - The Wall Street Journal Interactive Edition
Dow 30 Stock Roundup: Pfizer Scraps Astrazeneca Deal, CVX Production Growth on Track - Analyst Blog 11:19 a.m. May 30, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for May 10:21 a.m. May 30, 2014 - InvestorPlace.com
Teva gets favorable court ruling on generic Celebrex 9:28 a.m. May 30, 2014 - Seeking Alpha
Pfizer: Why A Major Acquisition Or Break-Up Is Needed 8:47 a.m. May 30, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Sanofi-Eli Lilly Collaborate for OTC Cialis - Analyst Blog 1:50 p.m. May 29, 2014 - Zacks.com
Dow Today: Pfizer (PFE) Higher 11:00 a.m. May 29, 2014 - TheStreet.com
IHG Faces Pressure to Seek Merger 9:38 a.m. May 29, 2014 - The Wall Street Journal Interactive Edition

Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. Today - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Pfizer Makes Final Proposal to AstraZeneca 5:03 p.m. May 18, 2014 - BusinessWire - BZX
Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 12:12 p.m. May 16, 2014 - BusinessWire - BZX
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...